Evidence map›Paper›PMID 29719671›Full record

ArticleMolecular autism2018

Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by

Silvia De Rubeis, Paige M Siper, Allison Durkin, Jordana Weissman, François Muratet, Danielle Halpern, Maria Del Pilar Trelles, Yitzchak Frank, Reymundo Lozano, A Ting Wang and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular autism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04003207 (An Open Label Trial of Growth Hormone in Children and Adolescents With Phelan-McDermid Syndrome Targeting Social Withdrawal), which is not on this map. Cited by 130 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 3 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04003207 phase2completednot on this mapstarted 2019, after this paper: background citation

An Open Label Trial of Growth Hormone in Children and Adolescents With Phelan-McDermid Syndrome Targeting Social Withdrawal

TypeinterventionalSponsorSwathi SethuramRan2019 to 2020Enrolled6ConditionsPhelan McDermid SyndromeArmsRecombinant human Growth hormone
3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 3 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Genetics of catatonia: a systematic review of case reports and a gene pathway analysis.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Science advances · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Altered Structural Plasticity Mediated by mGlu and NMDA Receptors and Impaired Cognition in a Genetic ASD Model (Shank3The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  18. Review
  19. Sex-dependent prediction of autism.Frontiers in genetics · 2026
    Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Silvia De Rubeis *1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0001-9383-6883
Paige M Siper *1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0002-9659-8232
Allison Durkin1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0002-8686-4146
Jordana Weissman1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0003-2798-4858
François Muratet1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.
Danielle Halpern1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0001-6745-1197
Maria Del Pilar Trelles1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0002-7442-3677
Yitzchak Frank1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0003-0979-1032
Reymundo Lozano1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0002-5616-5854
A Ting Wang1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0002-3322-679X
J Lloyd Holder6Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030 USA.ORCID 0000-0001-5595-0458
Catalina BetancurSorbonne Université, INSERM, CNRS, Neuroscience Paris Seine, Institut de Biologie Paris Seine, 75005 Paris, France.ORCID 0000-0002-3327-4804
Joseph D Buxbaum1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0001-8898-8313
Alexander Kolevzon1Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.ORCID 0000-0001-8129-2671
Icahn School of Medicine at Mount Sinai · USAllen Institute for Brain Science · USBaylor College of Medicine · USCentre National de la Recherche Scientifique · FRChild Health and Development Institute · US

Funding

Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI ALEXANDER KOLEVZON · 2014 to 2026
$20.1M
T32 training grant in medical genetics.T32GM082773 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Laszlo Tamas Kozicz, Eva Morava-Kozicz · 2008 to 2026
$4.9M
RESCUING MOTOR DEFICITS IN SHANK3 RELEATED DISORDERSK08NS091381 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI HOLDER, JIMMY L · 2015 to 2019
$908k
Piloting Treatment with Insulin-Like Growth Factor-1 in Phelan-McDermid SyndromeR34MH100276 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOLEVZON, ALEXANDER · 2013 to 2015
$740k
Development of Behavioral and Neural Biomarkers for Autism Spectrum Disorder Using a Genetically Defined SubtypeR21MH107839 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2016 to 2017
$444k
NIGMS NIH HHS T32 GM082773NIMH NIH HHS R21 MH107839NIMH NIH HHS R34 MH100276NINDS NIH HHS K08 NS091381NINDS NIH HHS U54 NS092090
6 · The paper itself

Abstract

Background: Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by psychiatric and neurological features. Most reported cases are caused by 22q13.3 deletions, leading to Methods: We provide detailed clinical and genetic data on 17 individuals carrying mutations in Results: Conclusions: Haploinsufficiency of

Indexed as

PhenotypePoint MutationAdolescentAdultChildChild, PreschoolChromosome DeletionChromosome DisordersChromosomes, Human, Pair 22FemaleHaploinsufficiencyHumansMaleNerve Tissue ProteinsNerve Tissue ProteinsSHANK3 protein, human22q13 deletion syndromeAutism spectrum disorderIntellectual disabilityPhelan-McDermid syndromePhenotypeSequence variantsSHANK3

Identifiers

PMID29719671
PMCPMC5921983
OpenAlexW2802837742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.